OPEN END TURBO CALL WARRANT - AMGEN | Market Closed - Deutsche Boerse AG 18:27:11 25/06/2024 BST | ||
| 1.43 EUR | +3.62% |
|
| Current month | +10.85% | ||
| 1 month | +9.16% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 25/06/24 | 1.43 | +3.62% |
| 24/06/24 | 1.38 | +2.99% |
| 21/06/24 | 1.34 | +0.75% |
| 20/06/24 | 1.33 | +5.56% |
| 19/06/24 | 1.26 | -3.08% |
Delayed Quote Deutsche Boerse AG
Last update June 25, 2024 at 06:27 pm
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UH2HC6 |
| ISIN | DE000UH2HC62 |
| Date issued | 03/09/2021 |
| Strike | 166.3 $ |
| Maturity | Unlimited |
| Parity | 100 : 1 |
| Emission price | 0.73 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.55 € |
|---|---|
| Lowest since issue | 0.43 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
319.3
USD
Average target price
316.4
USD
Spread / Average Target
-0.90%
- Stock Market
- Certificates
- Certificat
